CRISM Therapeutics Corporation

CRISM Therapeutics Corporationverified

CRTX.L

CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.

Industry

Biotechnology

IPO Date

2003-10-17

Stock Exchange

LSE

Ticker

CRTX.L

The Enterprise Value as of December 2025 (TTM) for CRISM Therapeutics Corporation (CRTX.L) is 5.38M

According to CRISM Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 5.38M. This represents a change of -1962.63% compared to the average of -288721.31 of the last 4 quarters.

CRISM Therapeutics Corporation (CRTX.L) Historical Enterprise Value (quarterly & annually)

How has CRTX.L Enterprise Value performed in the past?

The mean historical Enterprise Value of CRISM Therapeutics Corporation over the last ten years is 1.41B. The current 5.38M Enterprise Value has changed -61.90% with respect to the historical average. Over the past ten years (40 quarters), CRTX.L's Enterprise Value was at its highest in in the December 2016 quarter at 6.68B. The Enterprise Value was at its lowest in in the December 2023 quarter at -2786802.54.

Quarterly (TTM)
Annual

Average

1.41B

Median

21.36M

Minimum

-954614.37

Maximum

6.68B

CRISM Therapeutics Corporation (CRTX.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CRISM Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 25.93%

Maximum Annual Enterprise Value = 6.68B

Minimum Annual Increase = -106.86%

Minimum Annual Enterprise Value = -954614.37

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-445182.46-53.37%
2023-954614.37-106.86%
202213.92M-48.25%
202126.90M25.93%
202021.36M12.13%
201919.05M-44.41%
201834.28M-99.42%
20175.91B-11.57%

CRISM Therapeutics Corporation (CRTX.L) Average Enterprise Value

How has CRTX.L Enterprise Value performed in the past?

The current Enterprise Value of CRISM Therapeutics Corporation (CRTX.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.17M

5-year avg

12.16M

10-year avg

1.41B

CRISM Therapeutics Corporation (CRTX.L) Enterprise Value vs. Peers

How is CRTX.L’s Enterprise Value compared to its peers?

CRISM Therapeutics Corporation’s Enterprise Value is less than Tissue Regenix Group plc (15.48M), greater than Theracryf Plc (2.40M), greater than MyHealthChecked PLC (-504856.00), less than Proteome Sciences plc (22.80M), greater than N4 Pharma Plc (3.06M), less than Oxford BioDynamics Plc (6.42M), less than Cizzle Biotechnology Holdings Plc (5.98M), greater than Roquefort Therapeutics plc (2.19M), less than Chill Brands Group PLC (6.42M), greater than Feedback plc (-2510297.00),

Build a custom stock screener for CRISM Therapeutics Corporation (CRTX.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CRISM Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CRISM Therapeutics Corporation (CRTX.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CRISM Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is CRISM Therapeutics Corporation's Enterprise Value?

What is the highest Enterprise Value for CRISM Therapeutics Corporation (CRTX.L)?

What is the 3-year average Enterprise Value for CRISM Therapeutics Corporation (CRTX.L)?

What is the 5-year average Enterprise Value for CRISM Therapeutics Corporation (CRTX.L)?

How does the current Enterprise Value for CRISM Therapeutics Corporation (CRTX.L) compare to its historical average?